Value Dossier Icon

WS Value & Dossier GmbH

Your specialists for market access and reimbursement

How the German AMNOG process works

Value & Dossier GmbH advises pharmaceutical companies and biotechnology companies throughout the AMNOG process and on all matters relating to market access and reimbursement. Based on our long-standing expertise, we advise you on the development of the best strategy, the preparation of your benefit dossier for the G-BA assessment and the price negotiations with the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband).

Your success is what drives us. We will make sure that your new product will be reimbursed in the best possible way.

Our Services

All services at a glance

“We offer individual and company-specific solutions focussing on the value of the product while implementing it accordingly in the required benefit dossiers.”

Your team of specialists from Value & Dossier

f. l. t. r.: Dr. Hanna Klimek, Dr. Angela Lammert, Christopher Bell M. Sc., Julia Gerbeth M. Sc., Dr. Willi Schnorpfeil, Dr. Sandra Kiehlmeier, Michelle Woods M. Sc., Sandra Fraatz 

Recent Articles

Go to Top